Methotrexate LP16198-1
LOINC Hierarchy
| LOINC part code | LP16198-1 | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| name | Methotrexate | ||||||||||||||||||||||||
| type | COMPONENT | ||||||||||||||||||||||||
| status | ACTIVE | ||||||||||||||||||||||||
| mapping |
| ||||||||||||||||||||||||
| children | LOINC Home {component} LP432695-7 Laboratory LP29693-6 Drug toxicology LP7790-1 Drugs LP18046-0 Oncology drugs LP31428-3 Methotrexate LP16198-1 ▸ Methotrexate free LP207771-9▸ Methotrexate | Body fluid | Drug toxicology LP390955-5▸ Methotrexate | Cerebral spinal fluid | Drug toxicology LP390956-3▸ Methotrexate monoglutamate LP212193-9▸ Methotrexate diglutamate LP212194-7▸ Methotrexate | Serum or Plasma | Drug toxicology LP390957-1▸ Methotrexate | Urine | Drug toxicology LP390958-9▸ Methotrexate pentaglutamate LP212197-0▸ Methotrexate polyglutamates LP188434-7▸ Methotrexate tetraglutamate LP212196-2▸ Methotrexate triglutamate LP212195-4LOINC Home {component} LP432695-7 Laboratory LP29693-6 Drug doses LP7791-9 Oncology drugs LP31428-3 Methotrexate LP16198-1 ▸ Methotrexate | Dose | Drug doses LP392356-4 |
Copyright © 2023 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2023, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com